News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
744,292 Results
Type
Article (48115)
Company Profile (326)
Press Release (695837)
Multimedia
Podcasts (103)
Webinars (19)
Section
Business (209851)
Career Advice (2206)
Deals (36167)
Drug Delivery (129)
Drug Development (82784)
Employer Resources (196)
FDA (16597)
Job Trends (15348)
News (354053)
Policy (33463)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2757)
Academic (2)
Accelerated approval (31)
Adcomms (27)
Allergies (139)
Alliances (51167)
ALS (171)
Alzheimer's disease (1710)
Antibody-drug conjugate (ADC) (313)
Approvals (16849)
Artificial intelligence (539)
Autoimmune disease (146)
Automation (37)
Bankruptcy (367)
Best Places to Work (11831)
BIOSECURE Act (21)
Biosimilars (189)
Biotechnology (201)
Bladder cancer (158)
Brain cancer (56)
Breast cancer (640)
Cancer (4820)
Cardiovascular disease (403)
Career advice (1871)
Career pathing (39)
CAR-T (288)
CDC (50)
Celiac Disease (2)
Cell therapy (757)
Cervical cancer (37)
Clinical research (70335)
Collaboration (1733)
Company closure (4)
Compensation (1143)
Complete response letters (54)
COVID-19 (2789)
CRISPR (91)
C-suite (846)
Cystic fibrosis (144)
Data (6199)
Decentralized trials (2)
Denatured (41)
Depression (133)
Diabetes (499)
Diagnostics (6830)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (257)
Drug pricing (195)
Drug shortages (29)
Duchenne muscular dystrophy (230)
Earnings (90973)
Editorial (59)
Employer branding (25)
Employer resources (166)
Events (120885)
Executive appointments (992)
FDA (19699)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1499)
Gene editing (201)
Generative AI (47)
Gene therapy (607)
GLP-1 (1013)
Government (4820)
Grass and pollen (6)
Guidances (385)
Healthcare (19261)
HIV (56)
Huntington's disease (47)
IgA nephropathy (83)
Immunology and inflammation (252)
Immuno-oncology (54)
Indications (103)
Infectious disease (3053)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (112)
Intellectual property (247)
Interviews (349)
IPO (16871)
IRA (51)
Job creations (3854)
Job search strategy (1575)
JPM (59)
Kidney cancer (15)
Labor market (91)
Layoffs (573)
Leadership (33)
Legal (8112)
Liver cancer (93)
Longevity (14)
Lung cancer (650)
Lymphoma (374)
Machine learning (43)
Management (63)
Manufacturing (799)
MASH (164)
Medical device (13921)
Medtech (13974)
Mergers & acquisitions (20361)
Metabolic disorders (1281)
Multiple sclerosis (158)
NASH (22)
Neurodegenerative disease (320)
Neuropsychiatric disorders (87)
Neuroscience (2948)
Neurotech (1)
NextGen: Class of 2026 (6728)
Non-profit (4679)
Now hiring (66)
Obesity (609)
Opinion (281)
Ovarian cancer (166)
Pain (202)
Pancreatic cancer (225)
Parkinson's disease (287)
Partnered (35)
Patents (492)
Patient recruitment (475)
Peanut (57)
People (60894)
Pharmaceutical (73)
Pharmacy benefit managers (29)
Phase 1 (21932)
Phase 2 (30946)
Phase 3 (23049)
Pipeline (5123)
Policy (294)
Postmarket research (2644)
Preclinical (9532)
Press Release (72)
Prostate cancer (237)
Psychedelics (50)
Radiopharmaceuticals (283)
Rare diseases (833)
Real estate (6280)
Recruiting (76)
Regulatory (24903)
Reports (64)
Research institute (2547)
Resumes & cover letters (376)
Rett syndrome (27)
RNA editing (17)
RSV (78)
Schizophrenia (151)
Series A (250)
Series B (190)
Service/supplier (13)
Sickle cell disease (99)
Special edition (23)
Spinal muscular atrophy (160)
Sponsored (42)
Startups (3821)
State (2)
Stomach cancer (18)
Supply chain (107)
Tariffs (84)
The Weekly (60)
Vaccines (1026)
Venture capital (91)
Weight loss (398)
Women's health (89)
Worklife (20)
Date
Today (22)
Last 7 days (614)
Last 30 days (2009)
Last 365 days (30332)
2026 (2899)
2025 (30775)
2024 (35963)
2023 (40875)
2022 (51939)
2021 (56512)
2020 (54925)
2019 (47664)
2018 (35956)
2017 (33110)
2016 (32695)
2015 (38792)
2014 (32401)
2013 (27552)
2012 (29823)
2011 (30561)
2010 (29055)
Location
Africa (812)
Alabama (85)
Alaska (7)
Arizona (314)
Arkansas (14)
Asia (40923)
Australia (6744)
California (11266)
Canada (3278)
China (1101)
Colorado (481)
Connecticut (473)
Delaware (334)
Europe (89298)
Florida (1669)
Georgia (364)
Hawaii (4)
Idaho (62)
Illinois (871)
India (64)
Indiana (525)
Iowa (23)
Japan (424)
Kansas (127)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1387)
Massachusetts (8152)
Michigan (340)
Minnesota (647)
Mississippi (6)
Missouri (128)
Montana (31)
Nebraska (28)
Nevada (123)
New Hampshire (80)
New Jersey (3017)
New Mexico (30)
New York (2986)
North Carolina (1494)
North Dakota (10)
Northern California (5477)
Ohio (334)
Oklahoma (21)
Oregon (41)
Pennsylvania (2269)
Puerto Rico (22)
Rhode Island (47)
South America (1183)
South Carolina (65)
South Dakota (1)
Southern California (4379)
Tennessee (174)
Texas (1763)
United States (40213)
Utah (339)
Vermont (1)
Virginia (261)
Washington D.C. (86)
Washington State (923)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
744,292 Results for "gb sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Galecto to Highlight GB3226 Program at ASH 2025
November 4, 2025
·
5 min read
Press Releases
Targepeutics Announces Strategic Investment from Yuvaan Tiwari Foundation to Support Advancement of GB13 into Clinical Trials for DIPG
July 25, 2025
·
2 min read
Press Releases
Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 29, 2026
·
1 min read
Press Releases
Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting
April 8, 2025
·
9 min read
Press Releases
Kexing Biopharm’s GB18 project received clearance of IND application from NMPA and FDA
May 29, 2025
·
2 min read
Press Releases
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
November 10, 2025
·
3 min read
Biotech Bay
Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 DataCall scheduled for Tuesday, June 4, 2024 at 8:30 a.m. ET
Annexon, Inc. today announced that it will host a conference call and webcast on Tuesday, June 4, 2024, at 8:30 a.m. ET to discuss GBS phase 3 data.
June 3, 2024
·
1 min read
Press Releases
SK Life Science, Inc. Announces Publication of C035 Study Analyses in Epilepsia and Seizure
November 18, 2025
·
10 min read
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
Phacilitate’s annual event dawns as cell and gene therapies reach a new tipping point: the science has hit new heights just as regulatory and government policies spark momentum and frustration.
January 28, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Britannia Life Sciences Inc. Enters into $11.3 Million Share Exchange Agreement with McEwen Inc. and Britannia Mining Solutions Inc.
November 3, 2025
·
4 min read
1 of 74,430
Next
